Leila M Luheshi

Author PubWeight™ 17.90^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.	Proc Natl Acad Sci U S A	2013	2.89
2	Prefibrillar amyloid aggregates could be generic toxins in higher organisms.	J Neurosci	2006	1.89
3	Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.	Proc Natl Acad Sci U S A	2010	1.72
4	Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils.	PLoS Comput Biol	2007	1.71
5	Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms.	Proc Natl Acad Sci U S A	2014	1.48
6	ANS binding reveals common features of cytotoxic amyloid species.	ACS Chem Biol	2010	1.48
7	Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.	Neurosci Lett	2005	1.15
8	Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.	Biophys J	2010	0.99
9	Expression in drosophila of tandem amyloid β peptides provides insights into links between aggregation and neurotoxicity.	J Biol Chem	2012	0.90
10	Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.	FASEB J	2011	0.87
11	The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila.	PLoS One	2012	0.85
12	Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies.	Acta Neuropathol Commun	2014	0.79
13	Selenium-enhanced electron microscopic imaging of different aggregate forms of a segment of the amyloid β peptide in cells.	ACS Nano	2012	0.78
14	Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide.	ACS Chem Biol	2013	0.77
15	Methods and models in neurodegenerative and systemic protein aggregation diseases.	Front Biosci (Landmark Ed)	2010	0.76